Customizing solutions for your real world needs.
Epidemiological Studies analyses the effect of a certain medicine in large populations. It handles different tools, from prospective to retrospective options, and to choose between Registries, Comparative studies or clinical trials, it is critical to understand which are the strengths and limitations of each method for the development of an answer.
As a central aspect from Real World Evidence & Late Phase research, Epidemiology is a rigorous process which will support the strategy behind the product stablished goals. Eurotrials is able to develop the study design and study protocol to deliver this support and guarantee the project’s success.
Our team of epidemiologists, pharmacovigilance specialists, regulatory strategists and research operations combine a wide understanding and experience of the design, conduct and report of epidemiological studies, for different therapeutic areas at different regions. With one team in Europe and another in Latin America, Eurotrials capabilities for stand-alone epidemiologic studies has a strong reputation in the markets it operates, a settled record of publications in a variety of therapeutic areas.
Dedicated to your purposes, our Real World & Outcomes Research unit is constantly engaged with the latest trend in the Industry, by regularly attending key events like ISPOR, DIA Euromeeting and DIA Annual Meeting US, building strong knowledge foundations and moulding its approach with our Standard Operating Procedures (SOPs), so your study is handled with care and the right approach.
- Epidemiological effectiveness data for the creation of value new therapies
- Development of data regarding the clinical practice
- Support and strengthen of the product safety profile
- Support for orphan drug regulatory submissions
- Customized epidemiology data mining
- Support for and defense of regulatory decision making